FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Curium US Kit for the Preparation of Technetium Tc 99m Recall

Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, Each Kit contains: 30…

Curium US, LLC · Maryland Heights, MO

Risk level
Class II
Reported by FDA
Jan 1, 2025
Recall ID
D-0164-2025
Check your lot numberHow we source this data

Summary

Curium US recalled Kit for the Preparation of Technetium Tc 99m starting Nov 26, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0164-2025 on Jan 1, 2025. Reason: Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product

Product description

Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, Each Kit contains: 30 sterile and non-pyrogenic reaction vials each containing Tetrakis (2-methoxy isobutyl isonitrile) Copper (I) tetratluoroborate - 1 mg; Stannous Chloride Dihydrate - 0.D75 mg; L-Cysteine Hydrochloride Monohydrate - 1 mg; Sodium Citrate Dihydrate - 2.6 mg; Mannitol - 20 mg. The pH is adjusted to 5.6 to 5.7 with HCI or NaOH prior to lyophilization. Sealed under nitrogen. 30 Radioassay Information Labels with radiation warning symbol. 1 package insert, Rx only, Manufacture by: Curium US LLC, Maryland Heights, MO 63043, 69945-092-40

Lot numbers, UPCs & expiration codes

Lot 092-24006, Catalog # N092D0, Exp 06/15/2026

Where it was sold

Nationwide USA and Canada.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0164-2025
Classification
Class II
Status
Terminated
Recall initiated
Nov 26, 2024
FDA report date
Jan 1, 2025
Quantity
5,160 vials (172 kits 30 vials/kit)
Recall type
Voluntary: Firm initiated
Recalling firm
Curium US, LLC

Original FDA data

Every field from FDA enforcement report D-0164-2025, exactly as published.

Show all FDA fields
City
Maryland Heights
State
MO
Status
Terminated
Country
United States
Event ID
95839
Address
2703 Wagner Pl
Code information
Lot 092-24006, Catalog # N092D0, Exp 06/15/2026
Postal code
63043-3421
Report date
Jan 1, 2025
Product type
Drugs
Recall number
D-0164-2025
Classification
Class II
Recalling firm
Curium US, LLC
Product quantity
5,160 vials (172 kits 30 vials/kit)
Termination date
Oct 10, 2025
Reason for recall
Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product
Voluntary / mandated
Voluntary: Firm initiated
Product description
Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, Each Kit contains: 30 sterile and non-pyrogenic reaction vials each containing Tetrakis (2-methoxy isobutyl isonitrile) Copper (I) tetratluoroborate - 1 mg; Stannous Chloride Dihydrate - 0.D75 mg; L-Cysteine Hydrochloride Monohydrate - 1 mg; Sodium Citrate Dihydrate - 2.6 mg; Mannitol - 20 mg. The pH is adjusted to 5.6 to 5.7 with HCI or NaOH prior to lyophilization. Sealed under nitrogen. 30 Radioassay Information Labels with radiation warning symbol. 1 package insert, Rx only, Manufacture by: Curium US LLC, Maryland Heights, MO 63043, 69945-092-40
Distribution pattern
Nationwide USA and Canada.
Recall initiation date
Nov 26, 2024
Initial firm notification
Letter
Center classification date
Dec 26, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0164-2025, published Jan 1, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls